EADV 2026视频特辑｜Thierry Passeron教授：色素性疾病诊疗新进展——从机制认知到临床突破

Thierry Passeron 教授聚焦黄褐斑、白癜风两大常见色素性疾病，系统解读近一年领域内的关键研究进展、临床诊疗思路的转变方向，以及前沿在研疗法的研发进展。内容涵盖黄褐斑发病机制的新认知、临床治疗策略的优化方向，白癜风口服 JAK 抑制剂等系统治疗的循证证据与适用人群，同时解析了成纤维细胞这一色素疾病共性新靶点的研究价值，为临床医师与行业从业者提供专业学术参考。

Professor Thierry Passeron focuses on two common pigmentary disorders, melasma and vitiligo. He systematically interprets key research advances in the field over the past year, shifts in clinical diagnosis and treatment paradigms, and the progress of cutting-edge investigational therapies.

The content covers novel insights into melasma pathogenesis, optimization directions for clinical treatment strategies, as well as the evidence base and applicable populations of systemic vitiligo therapies including oral JAK inhibitors. It also analyzes the research value of fibroblasts as a new shared target for pigmentary disorders, providing professional academic reference for clinicians and industry practitioners.